The High Flux Reactor (HFR) at Petten in the Netherlands has initiated its first cycle of 2024 focusing on irradiating lutetium for medical applications.
NRG Pallas, which operates the HFR, said the cycle started on 19 January, with the reactor typically running eight to nine production cycles annually, supplying radioisotopes for treating a third of patients worldwide.
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options
